NeuroScientific Biopharmaceuticals Ltd NSB.AX
AUD0.06 AUD0.00 (6.25%) 1D
Last Updated: Aug 13, 12:00 AM·ASX
Pricing for AU stocks is delayed by 24 hours
NSB.AX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, NeuroScientific Biopharmaceuticals Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
NeuroScientific Biopharmaceuticals Ltd. Stock Analysis NSB.AX
Australia Health Care Nano Cap Neuroscientific Biopharmaceuticals Ltd. engages in researching and developing biomedical products targeting neurodegenerative conditions. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-07-27. The firm's product portfolio includes EmtinB, a therapeutic peptide initially targeting glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn and EmtinBn). EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury. Its StemSmart is a global patented technology engaged in manufacturing cell products. The use of its proprietary StemSmart technology in a special access program for fistulising Crohn’s disease.
NeuroScientific Biopharmaceuticals Ltd (NSB.AX) Chart
Financial Metrics & Statements of NeuroScientific Biopharmaceuticals Ltd (NSB.AX)
FAQ's for NeuroScientific Biopharmaceuticals Ltd (NSB.AX)
- As of August 2026, NeuroScientific Biopharmaceuticals Ltd NSB.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes NeuroScientific Biopharmaceuticals Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in NeuroScientific Biopharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of NeuroScientific Biopharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of NeuroScientific Biopharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of NeuroScientific Biopharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for NeuroScientific Biopharmaceuticals Ltd (NSB.AX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
